(Q61917296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

A Barnadas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Mendiola

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Casado

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Villar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Jimeno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Clerigue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Rosell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Cortés-Funes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M García de Paredes

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

312-315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

Potential role of oral anthracyclines in older patients with cancer

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900372-3

7 January 2021

Comparative phase II study of idarubicin versus doxorubicin in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900372-3

7 January 2021

A prospective randomized trial of doxorubicinversus idarubicin in the treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900372-3

7 January 2021

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900372-3

7 January 2021

Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900372-3

7 January 2021

Oral chemotherapy with idarubicin plus cyclophosphamide in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900372-3

7 January 2021

A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900372-3

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900372-3

7 January 2021

Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900372-3

7 January 2021

10.1016/S0959-8049(96)00372-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9135508%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference